Cumberland Pharmaceuticals CPIX Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's change in other liabilities?
- Cumberland Pharmaceuticals (CPIX) reported change in other liabilities of -$202.82K in Q1 2026.
- How has Cumberland Pharmaceuticals's change in other liabilities changed year-over-year?
- Cumberland Pharmaceuticals's change in other liabilities increased by 31.0% year-over-year, from -$293.94K to -$202.82K.
- What is the long-term trend for Cumberland Pharmaceuticals's change in other liabilities?
- Over 2 years (2021 to 2025), Cumberland Pharmaceuticals's change in other liabilities has grown at a -40.4% compound annual growth rate (CAGR), from -$1.34M to -$477.64K.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.